Seth Lederman

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TNXP

Current role

CEO, Board Member

2026-05-07–present

1 call Latest call 2026-08-10

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$702,000	$596,700	—	$1,870,130	—	—	$3,168,830
2024	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$675,000	$417,656	—	$717,111	—	—	$1,809,767
2023	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$675,000	—	—	$1,375,065	—	—	$2,050,065
2022	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$675,000	$355,000	—	$3,550,167	—	—	$4,580,167
2021	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$675,000	$506,250	—	$6,527,139	—	—	$7,708,389
2020	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$614,250	$460,688	—	$2,799,884	—	—	$3,874,822
2019	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$585,000	$198,095	—	$505,178	—	—	$1,288,273
2018	Tonix Pharmaceuticals Holding Corp. (TNXP)	Chief Executive Officer	$472,500	$160,000	—	$844,945	—	—	$1,477,445

Earnings-call appearances and filed executive appointments or departures, newest first.